Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Generex Biotechnology Corp

+ Add to Watchlist

GNBT:US

0.0159 USD 0.0019 13.57%

As of 20:10:00 ET on 01/30/2015.

Company Profile for Generex Biotechnology Corp (GNBT)

Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.

Contact Information

Generex Biotechnology Corp

33 Harbour Square
Suite 202
Toronto, ON M5J 2G2
Canada
Phone: 1-416-364-2551
Fax: 1-416-364-9363

Key Executives for Generex Biotechnology Corp (GNBT)

Mark A FletcherPresident/Exec VP/CEOStephen FellowsChief Financial Officer
David A BrusegardCOO/SecretaryEric Von HofeVice President
Todd FallsInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil